Pfizer Inc on Wednesday raised its full-year sales forecast for the COVID-19 vaccine it developed with Germany’s BioNTech by 29 per cent to US$33.5 billion, as nations stock up on doses for the rest of the year.
Source: ctv business
Pfizer raises 2021 COVID-19 vaccine sales forecast to US.5 billion

